TELEMAN DAN BENJAMIN enters NASUS PHARMA LTD with 6.25K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/27/2026ACC: 0001493152-26-013389
DirectorOfficer· Chief Executive Officer
Since Mar 2026
6.25K
Baseline shares
100% direct
6.25K
Direct ownership
1 position
318.86K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned6.25K
Total
6.25K direct6.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 6.25K | Direct |
| Total | 6.25K | 6.25K direct |
Derivative Holdings1
Share option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
318.86K
Shares owned
N/A
Exercise price
6.05
Expiration
—
Exercise window
—
Total
Underlying
318.86K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share option (right to buy) Direct | Ordinary Shares | 6.05 | — | — | 318.86K | N/A |
| Total | 318.86K | 0.00 | ||||